Literature DB >> 3017700

The phenotypic characteristics of simian sarcoma virus-transformed human fibroblasts suggest that the v-sis gene product acts solely as a PDGF receptor agonist in cell transformation.

A Johnsson, C Betsholtz, C H Heldin, B Westermark.   

Abstract

Previous studies have indicated that the oncogene v-sis of simian sarcoma virus (SSV) encodes a growth factor that is structurally and functionally similar to platelet-derived growth factor (PDGF). In the present investigation we have analysed the phenotypic characteristics of human foreskin fibroblasts transformed by SSV. It was found that the PDGF receptors were extensively down-regulated. This finding is consistent with a high, local, extracellular concentration of a PDGF-like factor, synthesized by the transformed cell. The receptors were up-regulated by suramin, a drug that is known to dissociate PDGF and the v-sis product from the PDGF receptors. A cell-associated v-sis product of mol. wt 24,000 was identified by immunoprecipitation with PDGF antibodies; release of this component was induced by a high concentration of exogenous PDGF, indicating that a fraction of the product is associated with the PDGF receptors. SSV was not found to be an immortalizing virus; when serially passaged, SSV-transformed cells had essentially the same life-span as their non-transformed counterparts. Moreover, SSV did not induce growth in soft agar beyond the level afforded by exogenously added PDGF. Thus, the present study favors the notion that SSV transformation is mediated by a growth factor that mimics PDGF but has no further cellular effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017700      PMCID: PMC1166977          DOI: 10.1002/j.1460-2075.1986.tb04394.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  Aging of human fibroblasts in vitro: surface features and behavior of aging WI 38 cells.

Authors:  P D Bowman; C W Daniel
Journal:  Mech Ageing Dev       Date:  1975 Mar-Apr       Impact factor: 5.432

2.  The growth capacity of normal and Rous-virus-transformed chicken fibroblasts in vitro.

Authors:  J Pontén
Journal:  Int J Cancer       Date:  1970-11-15       Impact factor: 7.396

3.  Demonstration of an antibody against platelet-derived growth factor.

Authors:  C H Heldin; B Westermark; A Wasteson
Journal:  Exp Cell Res       Date:  1981-12       Impact factor: 3.905

4.  Platelet-derived growth factor. III. Identification of a platelet-derived growth factor receptor by affinity labeling.

Authors:  K Glenn; D F Bowen-Pope; R Ross
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

5.  Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation.

Authors:  C H Heldin; A Wasteson; B Westermark
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

6.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

7.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

Authors:  S I Shin; V H Freedman; R Risser; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

8.  Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.

Authors:  A B Roberts; L C Lamb; D L Newton; M B Sporn; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus.

Authors:  A Johnsson; C Betsholtz; C H Heldin; B Westermark
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

10.  Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.

Authors:  G Blobel; B Dobberstein
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

View more
  15 in total

1.  Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Authors:  J Lu; S Y Chen; H H Chua; Y S Liu; Y T Huang; Y Chang; J Y Chen; T S Sheen; C H Tsai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  Recombinant DNA and surgery.

Authors:  J M Brown; A H Harken; J B Sharefkin
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

Review 3.  Platelet-derived growth factor: mechanism of action and possible in vivo function.

Authors:  C H Heldin; B Westermark
Journal:  Cell Regul       Date:  1990-07

Review 4.  Oncogenes and urological malignancies: implications for the future.

Authors:  J A Schalken; A M van den Ouweland; F M Debruijne; H F Karthaus; W J Van de Ven
Journal:  Urol Res       Date:  1988

5.  Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects.

Authors:  M Bywater; F Rorsman; E Bongcam-Rudloff; G Mark; A Hammacher; C H Heldin; B Westermark; C Betsholtz
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

6.  Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway.

Authors:  C Laker; C Stocking; U Bergholz; N Hess; J F De Lamarter; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Ultrastructural localization of a platelet-derived growth factor/v-sis-related protein(s) in cytoplasm and nucleus of simian sarcoma virus-transformed cells.

Authors:  H J Yeh; G F Pierce; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 8.  Platelet-derived growth factor as a mediator of normal and neoplastic cell proliferation.

Authors:  B Westermark; C H Heldin
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

9.  Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: alternative exon usage predicts two different precursor proteins.

Authors:  F Rorsman; M Bywater; T J Knott; J Scott; C Betsholtz
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

10.  Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene.

Authors:  M Pech; A Gazit; P Arnstein; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.